
|Articles|June 29, 2017
Santhera Selects Veeva Systems for Product Launch
Advertisement
Santhera Pharmaceuticals, rare disease pharmaceutical company, has selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The platform will be used to help Santhera establish a consistent, global approach to commercialization as it offers up-to-date customer reference data for field teams to enable faster, tailored interactions with HCPs.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
2
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
3
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
4
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
5




